Chief Physician, Doctoral Supervisor, Chief Physician of the Leukemia Center (Founder of CAR-T Therapy)
Affiliated HospitalInstitute of Hematology, Chinese Academy of Medical Sciences (Chinese Academy of Medical Sciences Institute of Hematology)
→
Research areas : Acute leukemia, CAR-T research and development, targeted immunotherapy for hematological malignancies; Cutting-edge technologies: Domestically developed CD19 CAR-T, IL10R novel target CAR-T; Diseases of expertise: Acute myeloid leukemia, acute lymphoblastic leukemia; Academic highlights: Chairman of the Hematology Branch of the Chinese Medical Association, Head of CNCT19 CAR-T research and development; Core value: Pioneering a domestically developed CAR-T technology system with independent intellectual property rights and completing the industrialization of the technology.